Drug-resistant malaria in Bangui, Central African Republic: An in vitro assessment

American Journal of Tropical Medicine and Hygiene

Volumn 73, Issue 2, 2005, Pages 239-243

  Menard, Didier ^a   Djalle, Djibrine ^b   Manirakiza, Alexandre ^b   Yapou, Ferdinand ^b   Siadoua, Valerie ^b   Sana, Serge ^b   Matsika Claquin, Marcelle Diane ^b   Nestor, Madji ^c   Talarmin, Antoine ^b  

^a INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^b INSTITUT PASTEUR DE BANGUI   (Central African Republic)

^c National Malaria Control Program   (Central African Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ATOVAQUONE; CHLOROQUINE; DEETHYLAMODIAQUINE; DIHYDROARTEMISININ; DOXYCYCLINE; HALOFANTRINE; MEFLOQUINE; PYRIMETHAMINE; QUININE;

ARTICLE; CENTRAL AFRICA; DRUG SENSITIVITY; IN VITRO STUDY; MALARIA; MULTIDRUG RESISTANCE; NONHUMAN; PLASMODIUM FALCIPARUM;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM;

EID: 24644457679     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2005.73.239     Document Type: Article

References (29)

1. WHO, 2003. African Malaria Report. Geneva: World Health Organization. WHO/CDS/MAL/2003.1093. http://rbm.who.int/publications.
2. Pierce PF, Milhous WK, Campbell CC, 1987. Clinical and laboratory characterization of a chloroquine-resistant Plasmodium falciparum strain acquired in the Central African Republic. Am J Trop Med Hyg 36: 1-2.
3. Belec L, Delmont J, Vesters I, Testa J, Christian KS, Georges AJ, 1988. Emergence of multiresistant Plasmodium falciparum malaria in Central African Republic. Presse Med 17: 2090-2091.
4. Menard D, Madji N, Manirakiza A, Djalle D, Koula MR, Talarmin A, 2005. Efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, chloroquine-sulfadoxine-pyrimethamine combination, and amodiaquine-sulfadoxine- pyrimethamine combination in central African children with non-complicated malaria. Am J Trop Med Hyg 72: 581-585.
5. Ministère du plan et de la coopération internationale, UNICEF, 2001. Enquête àindicateurs multiples, MICS 2000, Rapport final Bangui Avril 2001. BBA Editions: 130-131
6. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD, 1979. Quantitative assessment of antimalarial activity in vitro by a semi-automated microdilution technique. Antimicrob Agents Chemother 16: 710-718.
7. Le Bras J, Ringwald P, 1990. Plasmodium falciparum chemoresistance. The situation in Africa in 1989. Med Trop (Mars) 50: 11-16.
8. Le Bras J, Simon F, Ramanamirija JA, Calmel MB, Hatin I, Deloron P, Porte J, Marchais H, Clausse JL, Biaud JM, 1987. Sensitivity of Plasmodium falciparum to quinolines and therapeutic strategies: comparison of the situation in Africa and Madagascar between 1983 and 1986. Bull Soc Pathol Exot 80: 477-489.
9. Basco LK, Le Bras J, 1994. In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives. Ann Trop Med Parasitol 88: 137-144.
10. Hatin I, Trape JF, Legros F, Bauchet J, Le Bras J, 1992. Susceptibility of Plasmodium falciparum strains to mefloquine in an urban area in Senegal. Bull World Health Organ 70: 363-367.
11. Basco LK, Le Bras J, 1992. In vitro activity of halofantrine and its relationship to other standard antimalarial drugs against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg 47: 521-527.
12. Gay F, Bustos D, Traore B, Jardinel C, Southammavong M, Ciceron L, Danis M, 1997. In vitro response of Plasmodium falciparum to atovaquone and correlation with other antimalarials: comparison between African and Asian strains. Am J Trop Med Hyg 56: 315-317.
13. Basco LK, Eldin de Pecoulas P, Wilson CM, Le Bras J, Mazabraud A, 1995. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol Biochem Parasitol 69: 135-138.
14. Mezui Me Ndong J, Atteke C, Aubouy A, Bakary M, Lébibi J, Deloron P, 2003. In vitro activity of chloroquine, quinine, mefloquine and halofantrine against Gabonese isolates of Plasmodium falciparum. Trop Med Int Health 8: 25-29.
15. Ringwald P, Bickii J, Basco LK, 1999. In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Am J Trop Med Hyg 61:187-192.
16. Bergeri I, Zoguereh DD, Madji N, Barrau K, Delmont J, Namsenmo A, Ndoyo J, 2003. In vivo evaluation of chloroquine therapeutic efficacy in uncomplicated Plasmodium falciparum malaria in Central African Republic in 1997 and 1998. Bull Soc Pathol Exot 96: 29-34.
17. Carme B, Gay F, Ndounga M, Hayette-Gorremans MP, Bouquety JC, 1995. In vitro drug sensitivity and clinical aspects of Plasmodium falciparum malaria in African children. Trop Med Parasitol 46: 270-274.
18. Ouedraogo JB, Dutheil Y, Tinto H, Traore B, Zampa H, Tall F, Coulibaly SO, Guiguemde TR, 1998. In vitro sensitivity of Plasmodium falciparum to halofantrine compared with chloroquine, quinine and mefloquine in the region of Bobo-Dioulasso, Burkina Faso (West Africa). Trop Med Int Health 3: 381-384.
19. Ringwald P, Bickii J, Basco LK, 1996. In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Am J Trop Med Hyg 55: 254-258.
20. Pradines B, Mabika Mamfoumbi M, Parzy D, Owono Medang M, Lebeau C, Mourou Mbina JR, Doury JC, Kombila M, 1998. In vitro susceptibility of Gabonese wild isolates of Plasmodium falciparum to artemether, and comparison with chloroquine, quinine, halofantrine and amodiaquine. Parasitology 117:541-545.
21. Philipps J, Radloff PD, Wernsdorfer W, Kremsner PG, 1998. Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon. Am J Trop Med Hyg 58: 612-618.
22. Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe PN, Djimde AA, Kouriba B, Taylor TE, Plowe CV, 2003. Re-emergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis 187: 1870-1875.
23. Hyde JE, 2002. Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs. Microbes Infect 4: 165-174.
24. Thanh NV, Cowman AF, Hipgrave D, Kim TB, Phuc BQ, Cong LD, Biggs BA, 2001. Assessment of susceptibility of Plasmodium falciparum to chloroquine, quinine, mefloquine, sulfadoxine-pyrimethamine and artemisinin in southern Vietnam. Trans R Soc Trop Med Hyg 95: 513-517.
25. Noedl H, Faiz MA, Yunus EB, Rahman MR, Hossain MA, Samad R, Miller RS, Pang LW, Wongsrichanalai C, 2003. Drug-resistant malaria in Bangladesh: an in vitro assessment. Am J Trop Med Hyg 68: 140-142.
26. Basco LK, Le Bras J, 1993. In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg 49: 301-307.
27. Bustos MDG, Gay F, Diquet B, 1994. In vitro tests on Philippine isolates of Plasmodium falciparum against four standard anti-malarials and four qinghaosu derivatives. Bull World Health Organ 72: 729-735.
28. Pradines B, Rogier C, Fusai T, Tall A, Trape JF, Doury JC, 1998. In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs. Am J Trop Med Hvg 58: 354-357.
29. Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, Kimura M, O'Neill PM, Bray PG, Ward SA, Krishna S, 2003. Artemisinins target the SERCA of Plasmodium falciparum. Nature 424: 957-961.